Armed with a passion to eradicate the deadliest of all cancers, Eric Tran, Ph.D., and Rom Leidner, M.D., have pioneered a second-generation adoptive cell therapy using genetically engineered T cells. Read about their innovative work in the New England Journal of Medicine article Neoantigen T-Cell Receptor-Gene Therapy in Pancreatic Cancer.
